VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis
Background Single nucleotide polymorphisms (SNPs) in vascular endothelial growth factor A (VEGFA) are associated with susceptibility to several diseases including cancer. Correlations between VEGFA rs3025020 genotypes with clinical and laboratory features of primary myelofibrosis (PMF) are unstudied...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Georg Thieme Verlag KG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e906254e58584b989aaa9b12fede141e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e906254e58584b989aaa9b12fede141e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e906254e58584b989aaa9b12fede141e2021-11-09T23:57:38ZVEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis2512-946510.1055/s-0041-1739293https://doaj.org/article/e906254e58584b989aaa9b12fede141e2021-10-01T00:00:00Zhttp://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1739293https://doaj.org/toc/2512-9465Background Single nucleotide polymorphisms (SNPs) in vascular endothelial growth factor A (VEGFA) are associated with susceptibility to several diseases including cancer. Correlations between VEGFA rs3025020 genotypes with clinical and laboratory features of primary myelofibrosis (PMF) are unstudied. Methods DNA was analyzed by real-time polymerase chain reaction for VEGFA rs3025020 genotypes in a cohort of 844 subjects with PMF and in two cohorts of normal subjects (N = 247 and N = 107). Results Frequency of rs3025020 minor allele (T) was not significantly different in subjects with PMF compared with normals; however, the T-allele was more frequent in PMF subjects with a calreticulin (CALR)-mutated genotype compared with normals (35 vs. 27%; OR = 1.47 [95% CI, 1.09, 1.98] p = 0.011), especially in subjects with a CALR-type 2/type 2-like mutation (43 vs. 27%; OR = 2.01 [1.25, 3.24] p = 0.004). CALR mutants with the rs3025020 TT genotype had higher CXCR4 expression on CD34-positive blood cells, and those who carried CT/TT genotypes had lower platelet concentrations compared with other genotypes at diagnosis. Overall, subjects with the rs3025020 CT/TT genotype had a lower cumulative incidence of deep vein thrombosis in typical sites (1.6 vs. 4.2%; OR = 0.37 [0.15, 0.90] p = 0.029) and longer interval from diagnosis to first thrombosis (HR = 0.37 [0.14, 0.95] p = 0.039). Conclusion Persons with PMF and the VEGFA rs3025020 minor T-allele are more likely to have a CALR mutation compared with other somatic driver mutations and lower cumulative incidence and hazard for deep vein thrombosis in typical sites.Laura VillaniVittorio RostiMargherita MassaRita CampanelliPaolo CatarsiAdriana CaroleiCarlotta AbbàAnnalisa de SilvstriRobert Peter GaleGiovanni BarosiGeorg Thieme Verlag KGarticleprimary myelofibrosis vegfa polymorphism rs3025020 deep vein thrombosis calr mutationDiseases of the circulatory (Cardiovascular) systemRC666-701ENTH Open, Vol 05, Iss 04, Pp e513-e520 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
primary myelofibrosis vegfa polymorphism rs3025020 deep vein thrombosis calr mutation Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
primary myelofibrosis vegfa polymorphism rs3025020 deep vein thrombosis calr mutation Diseases of the circulatory (Cardiovascular) system RC666-701 Laura Villani Vittorio Rosti Margherita Massa Rita Campanelli Paolo Catarsi Adriana Carolei Carlotta Abbà Annalisa de Silvstri Robert Peter Gale Giovanni Barosi VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis |
description |
Background Single nucleotide polymorphisms (SNPs) in vascular endothelial growth factor A (VEGFA) are associated with susceptibility to several diseases including cancer. Correlations between VEGFA rs3025020 genotypes with clinical and laboratory features of primary myelofibrosis (PMF) are unstudied.
Methods DNA was analyzed by real-time polymerase chain reaction for VEGFA rs3025020 genotypes in a cohort of 844 subjects with PMF and in two cohorts of normal subjects (N = 247 and N = 107).
Results Frequency of rs3025020 minor allele (T) was not significantly different in subjects with PMF compared with normals; however, the T-allele was more frequent in PMF subjects with a calreticulin (CALR)-mutated genotype compared with normals (35 vs. 27%; OR = 1.47 [95% CI, 1.09, 1.98] p = 0.011), especially in subjects with a CALR-type 2/type 2-like mutation (43 vs. 27%; OR = 2.01 [1.25, 3.24] p = 0.004). CALR mutants with the rs3025020 TT genotype had higher CXCR4 expression on CD34-positive blood cells, and those who carried CT/TT genotypes had lower platelet concentrations compared with other genotypes at diagnosis. Overall, subjects with the rs3025020 CT/TT genotype had a lower cumulative incidence of deep vein thrombosis in typical sites (1.6 vs. 4.2%; OR = 0.37 [0.15, 0.90] p = 0.029) and longer interval from diagnosis to first thrombosis (HR = 0.37 [0.14, 0.95] p = 0.039).
Conclusion Persons with PMF and the VEGFA rs3025020 minor T-allele are more likely to have a CALR mutation compared with other somatic driver mutations and lower cumulative incidence and hazard for deep vein thrombosis in typical sites. |
format |
article |
author |
Laura Villani Vittorio Rosti Margherita Massa Rita Campanelli Paolo Catarsi Adriana Carolei Carlotta Abbà Annalisa de Silvstri Robert Peter Gale Giovanni Barosi |
author_facet |
Laura Villani Vittorio Rosti Margherita Massa Rita Campanelli Paolo Catarsi Adriana Carolei Carlotta Abbà Annalisa de Silvstri Robert Peter Gale Giovanni Barosi |
author_sort |
Laura Villani |
title |
VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis |
title_short |
VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis |
title_full |
VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis |
title_fullStr |
VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis |
title_full_unstemmed |
VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis |
title_sort |
vegfa rs3025020 polymorphism contributes to calr-mutation susceptibility and is associated with low risk of deep vein thrombosis in primary myelofibrosis |
publisher |
Georg Thieme Verlag KG |
publishDate |
2021 |
url |
https://doaj.org/article/e906254e58584b989aaa9b12fede141e |
work_keys_str_mv |
AT lauravillani vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis AT vittoriorosti vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis AT margheritamassa vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis AT ritacampanelli vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis AT paolocatarsi vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis AT adrianacarolei vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis AT carlottaabba vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis AT annalisadesilvstri vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis AT robertpetergale vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis AT giovannibarosi vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis |
_version_ |
1718440798821810176 |